The University of Chicago Header Logo

Connection

Olatoyosi Odenike to Double-Blind Method

Back to Details
This is a "connection" page, showing publications Olatoyosi Odenike has written about Double-Blind Method.
Olatoyosi Odenike
Connection Strength
0.024
Double-Blind Method
  1. Vosaroxin plus cytarabine versus placebo plus cytarabine in patients with first relapsed or refractory acute myeloid leukaemia (VALOR): a randomised, controlled, double-blind, multinational, phase 3 study. Lancet Oncol. 2015 Sep; 16(9):1025-1036.
    View in: PubMed
    Score: 0.024
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.